Are you Dr. Mahler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3220 Tallyho LN
Madison, WI 53705Phone+1 608-233-6732
Summary
- Dr. Peter Mahler, MD is a radiation oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Illinois. He is affiliated with University Hospital and Fort HealthCare.
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1987 - 1991
- University of Washington School of MedicineClass of 1987
- University of Wisconsin Hospitals and ClinicsFellowship, Hospice and Palliative Medicine
Certifications & Licensure
- WI State Medical License 1988 - 2023
- IL State Medical License 1994 - 2020
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 10 citationsReduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancerSangjune Laurence Lee, P.A. Mahler, S.J. Olson, Jacob S. Witt, Hima Bindu Musunuru
Medical Dosimetry. 2021-06-01 - 2 citationsThree discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune responseClemens Grassberger, Kathryn E. Huber, Naduparambil K. Jacob, Michael D. Green, Peter A. Mahler
Journal of Applied Clinical Medical Physics. 2019-10-01 - 59 citationsReirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy.Jarrod B. Adkison, Wolfgang A. Tomé, Songwon Seo, Gregory M. Richards, H. Ian Robins
International Journal of Radiation Oncology, Biology, Physics. 2011-03-01
Press Mentions
- New Coronavirus Strain Discovered in Ohio, Current Vaccines Believed Effective Against ItJanuary 13th, 2021
- Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: The Single Most Important Factor in Determining the Future of SBRT Is Immune ResponseOctober 3rd, 2019